Close Menu

NEW YORK (360Dx) – Accelerate Diagnostics said on Sunday that it anticipates its fourth quarter revenues to be down 14 percent year over year.

Accelerate's total fourth quarter revenues are expected to retreat to approximately $1.8 million from $2.1 million a year ago. The figure would miss the analysts' average estimate of $2.7 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.